James Schultz

Array ( [id] => 6415556 [patent_doc_number] => 20020183496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Human thymosin beta15 gene, protein and uses thereof' [patent_app_type] => new [patent_app_number] => 09/874736 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10622 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183496.pdf [firstpage_image] =>[orig_patent_app_number] => 09874736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1266360 [patent_doc_number] => 06656688 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Antisense modulation of NF-kappa-B p65 subunit expression' [patent_app_type] => B1 [patent_app_number] => 09/856747 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24403 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656688.pdf [firstpage_image] =>[orig_patent_app_number] => 09856747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450560 [patent_doc_number] => 20020177568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Enzymatic nucleic acid treatment of diseases or conditions related to levels of NF-kappa B' [patent_app_type] => new [patent_app_number] => 09/864785 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 53157 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177568.pdf [firstpage_image] =>[orig_patent_app_number] => 09864785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 671794 [patent_doc_number] => 07090841 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-15 [patent_title] => 'Use of CD63 inhibitors' [patent_app_type] => utility [patent_app_number] => 09/846506 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6623 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/090/07090841.pdf [firstpage_image] =>[orig_patent_app_number] => 09846506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080384 [patent_doc_number] => 20020081601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2' [patent_app_type] => new [patent_app_number] => 09/841963 [patent_app_country] => US [patent_app_date] => 2001-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31063 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081601.pdf [firstpage_image] =>[orig_patent_app_number] => 09841963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385956 [patent_doc_number] => 20040180336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Method for enrichment of natural antisense messenger RNA' [patent_app_type] => new [patent_app_number] => 09/833031 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7736 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180336.pdf [firstpage_image] =>[orig_patent_app_number] => 09833031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469512 [patent_doc_number] => 20040054129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Novel peptides and compositions which modulate apoptosis' [patent_app_type] => new [patent_app_number] => 09/828870 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13687 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054129.pdf [firstpage_image] =>[orig_patent_app_number] => 09828870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750459 [patent_doc_number] => 20030044979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Antisense modulation of phospholipid scramblase I expression' [patent_app_type] => new [patent_app_number] => 09/828344 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26807 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044979.pdf [firstpage_image] =>[orig_patent_app_number] => 09828344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6156850 [patent_doc_number] => 20020146449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Compositions and methods for the targeted delivery of agents to treat liver cancer' [patent_app_type] => new [patent_app_number] => 09/827255 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4536 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146449.pdf [firstpage_image] =>[orig_patent_app_number] => 09827255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745665 [patent_doc_number] => 20030022848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression' [patent_app_type] => new [patent_app_number] => 09/824322 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 36705 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022848.pdf [firstpage_image] =>[orig_patent_app_number] => 09824322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530654 [patent_doc_number] => 20020136761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides' [patent_app_type] => new [patent_app_number] => 09/816138 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7004 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136761.pdf [firstpage_image] =>[orig_patent_app_number] => 09816138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095813 [patent_doc_number] => 20020052037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Nucleic acid catalysts comprising L-nucleotide analogs' [patent_app_type] => new [patent_app_number] => 09/812186 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11027 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052037.pdf [firstpage_image] =>[orig_patent_app_number] => 09812186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788345 [patent_doc_number] => 20030139584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'TREX, a novel gene of TRAF-interacting EXT gene family and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 09/809920 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20643 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139584.pdf [firstpage_image] =>[orig_patent_app_number] => 09809920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7064885 [patent_doc_number] => 20010044145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Methods of using mammalian RNase H and compositions thereof' [patent_app_type] => new [patent_app_number] => 09/799848 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16215 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044145.pdf [firstpage_image] =>[orig_patent_app_number] => 09799848 [rel_patent_id] =>[rel_patent_doc_number] =>)